Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Lung Neoplasms × Photochemotherapy × Clear all

Phase

Status

Withdrawn 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Tongue Neoplasms 1 Photosensitivity Disorders 1 Mesothelioma, Malignant 1 Lung Neoplasms 1 Keratosis, Actinic 1 Gallbladder Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Bile Duct Neoplasms 1

Interventions

Carboplatin 14 Radiotherapy 9 Cisplatin 8 durvalumab 6 Pemetrexed 6 Paclitaxel 6 Magnetic Resonance Spectroscopy 5 Radiosurgery 4 Nivolumab 4 Gemcitabine 4 Etoposide 4 Docetaxel 4 pembrolizumab 3 Surveys and Questionnaires 3 Radiation 3 Erlotinib Hydrochloride 3 Bevacizumab 3 sapanisertib 2 etoposide phosphate 2 Vinorelbine 2 Taxes 2 Standard of Care 2 Specimen Handling 2 Platinum 2 Methylprednisolone 2 Indocyanine Green 2 Immunoglobulin G 2 Gefitinib 2 Drug Therapy 2 Disulfides 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03346304 2019-02-01

PEARL

University College, London

Phase 2/3 Withdrawn

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡